Literature DB >> 8373903

Severe autoimmune hemolytic anemia with cold agglutinin and sclerodermic features--favorable response to danazol.

G Lugassy1, T Reitblatt, A Ducach, S Oren.   

Abstract

A rare case of severe primary autoimmune hemolytic anemia with cold agglutinin and extensive cutaneous sclerodermic changes is reported. This association has not been previously documented in the literature. The anemia was refractory to steroids but responded to danazol treatment. Danazol may be an effective therapy in some cases of autoimmune hemolytic anemia with cold agglutinin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373903     DOI: 10.1007/bf01701740

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  11 in total

1.  Immunopathologic and clinical features of hemolytic anemia due to cold agglutinins.

Authors:  U E Nydegger; M D Kazatchkine; P A Miescher
Journal:  Semin Hematol       Date:  1991-01       Impact factor: 3.851

2.  Cold agglutinin hemolytic anemia: management with an environmental suit.

Authors:  J R Bartholomew; W R Bell; R S Shirey
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

3.  The variability of hemolysis in the cold agglutinin syndrome.

Authors:  W F Rosse; J P Adams
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

4.  Cold agglutinin autoimmune hemolytic anemia in nonhematologic malignancies.

Authors:  J Wortman; W Rosse; G Logue
Journal:  Am J Hematol       Date:  1979       Impact factor: 10.047

5.  Danazol therapy for autoimmune hemolytic anemia.

Authors:  Y S Ahn; W J Harrington; R Mylvaganam; J Ayub; L M Pall
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

6.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.

Authors:  J A Gelfand; R J Sherins; D W Alling; M M Frank
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

Review 7.  Autoimmune hemolytic anemia and cold hemagglutinin disease: clinical disease and laboratory findings.

Authors:  P D Issitt
Journal:  Prog Clin Pathol       Date:  1978

8.  Danazol for the treatment of idiopathic thrombocytopenic purpura.

Authors:  Y S Ahn; W J Harrington; S R Simon; R Mylvaganam; L M Pall; A G So
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

9.  [Efficacy of danazol in autoimmune hemolytic anemia with cold agglutinins. 4 cases].

Authors:  E Geffray; A Najman
Journal:  Presse Med       Date:  1992-09-26       Impact factor: 1.228

10.  B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins).

Authors:  D Crisp; W Pruzanski
Journal:  Am J Med       Date:  1982-06       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.